+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Coronary Stents (Cardiovascular Devices) - Medical Devices Pipeline Product Landscape, 2021

  • PDF Icon

    Report

  • 260 Pages
  • October 2021
  • Region: Global
  • GlobalData
  • ID: 5460003
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Coronary Stents (Cardiovascular Devices) - Medical Devices Pipeline Product Landscape, 2021

Summary


This Medical Devices sector report, “Coronary Stents (Cardiovascular Devices) - Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Coronary Stents pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

A stent is an expandable perforated tube that is inserted into a natural conduit of the body to prevent or counteract a disease-induced localized flow constriction. The main goal of the stent is to hold the inner wall in its compressed position and retain the enlarged vessel diameter. Coronary stents are used in the coronary vasculature and include bioabsorbable stents (BAS), drug eluting stents (DES), bare metal stents (BMS) and covered stents.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope


  • Extensive coverage of the Coronary Stents under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Coronary Stents and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy


The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Coronary Stents under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Coronary Stents Overview
3 Products under Development
3.1 Coronary Stents - Pipeline Products by Stage of Development
3.2 Coronary Stents - Pipeline Products by Segment
3.3 Coronary Stents - Pipeline Products by Territory
3.4 Coronary Stents - Pipeline Products by Regulatory Path
3.5 Coronary Stents - Pipeline Products by Estimated Approval Date
3.6 Coronary Stents - Ongoing Clinical Trials
4 Coronary Stents - Pipeline Products under Development by Companies
4.1 Coronary Stents Companies - Pipeline Products by Stage of Development
4.2 Coronary Stents - Pipeline Products by Stage of Development
5 Coronary Stents Companies and Product Overview
5.1 Abbott Vascular Inc Company Overview
5.1.1 Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 Adcomp Technologies Inc. Company Overview
5.2.1 Adcomp Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.3 Advanced Bifurcation Systems Inc Company Overview
5.3.1 Advanced Bifurcation Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
5.4 Aeon Bioscience Company Overview
5.4.1 Aeon Bioscience Pipeline Products & Ongoing Clinical Trials Overview
5.5 AlviMedica Medical Technologies Inc Company Overview
5.5.1 AlviMedica Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.6 Amaranth Medical Inc Company Overview
5.6.1 Amaranth Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.7 Atrium Medical Corp Company Overview
5.7.1 Atrium Medical Corp Pipeline Products & Ongoing Clinical Trials Overview
5.8 Axordia Ltd (Inactive) Company Overview
5.8.1 Axordia Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.9 B. Braun Melsungen AG Company Overview
5.9.1 B. Braun Melsungen AG Pipeline Products & Ongoing Clinical Trials Overview
5.10 Bactiguard Holding AB Company Overview
5.10.1 Bactiguard Holding AB Pipeline Products & Ongoing Clinical Trials Overview
5.11 Bionext Biotech Products Ltd. Company Overview
5.11.1 Bionext Biotech Products Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.12 Biosensors International Group Ltd Company Overview
5.12.1 Biosensors International Group Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.13 Biosten, LLC Company Overview
5.13.1 Biosten, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.14 Biotronik AG Company Overview
5.14.1 Biotronik AG Pipeline Products & Ongoing Clinical Trials Overview
5.15 Biotronik SE & Co KG Company Overview
5.15.1 Biotronik SE & Co KG Pipeline Products & Ongoing Clinical Trials Overview
5.16 Biotyx Medical Company Overview
5.16.1 Biotyx Medical Pipeline Products & Ongoing Clinical Trials Overview
5.17 Boston Scientific Corp Company Overview
5.17.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
5.18 Cardionovum GmbH Company Overview
5.18.1 Cardionovum GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.19 Cardiorev Pte Ltd (Inactive) Company Overview
5.19.1 Cardiorev Pte Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.20 Columbia University Company Overview
5.20.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview
5.21 Concept Medical Inc Company Overview
5.21.1 Concept Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.22 Contego Medical LLC Company Overview
5.22.1 Contego Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
5.23 Cordis Corp Company Overview
5.23.1 Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview
5.24 Cytograft Tissue Engineering Inc (Inactive) Company Overview
5.24.1 Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.25 DISA Vascular (Pty) Ltd Company Overview
5.25.1 DISA Vascular (Pty) Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.26 Elixir Medical Corp Company Overview
5.26.1 Elixir Medical Corp Pipeline Products & Ongoing Clinical Trials Overview
5.27 Envision Scientific Pvt Ltd Company Overview
5.27.1 Envision Scientific Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.28 HangZhou HuaAn Biotechnology Co., Ltd. Company Overview
5.28.1 HangZhou HuaAn Biotechnology Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.29 I.B.S. S.p.A. Company Overview
5.29.1 I.B.S. S.p.A. Pipeline Products & Ongoing Clinical Trials Overview
5.30 Icon Interventional Systems, Inc. Company Overview
5.30.1 Icon Interventional Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.31 ID Nest Medical SAS Company Overview
5.31.1 ID Nest Medical SAS Pipeline Products & Ongoing Clinical Trials Overview
5.32 InspireMD Inc Company Overview
5.32.1 InspireMD Inc Pipeline Products & Ongoing Clinical Trials Overview
5.33 Japan Stent Technology Co., Ltd. Company Overview
5.33.1 Japan Stent Technology Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.34 JW Medical Systems Ltd Company Overview
5.34.1 JW Medical Systems Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.35 Kaneka Corp Company Overview
5.35.1 Kaneka Corp Pipeline Products & Ongoing Clinical Trials Overview
5.36 Kyoto Medical Planning Co Ltd Company Overview
5.36.1 Kyoto Medical Planning Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.37 Liaoning Biomedical Materials R&D Center Co Ltd Company Overview
5.37.1 Liaoning Biomedical Materials R&D Center Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.38 Lifetech Scientific (Shenzhen) Co Ltd Company Overview
5.38.1 Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.39 MangoGen Pharma Inc Company Overview
5.39.1 MangoGen Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview
5.40 Manli Cardiology Ltd Company Overview
5.40.1 Manli Cardiology Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.41 Medinol Ltd Company Overview
5.41.1 Medinol Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.42 Medlogics Device Corp (Inactive) Company Overview
5.42.1 Medlogics Device Corp (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.43 Medtronic Plc Company Overview
5.43.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
5.44 Meril Life Sciences Pvt Ltd Company Overview
5.44.1 Meril Life Sciences Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.45 Miami Cardiovascular Innovations Company Overview
5.45.1 Miami Cardiovascular Innovations Pipeline Products & Ongoing Clinical Trials Overview
5.46 Micell Technologies Inc Company Overview
5.46.1 Micell Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.47 Michigan Technological University Company Overview
5.47.1 Michigan Technological University Pipeline Products & Ongoing Clinical Trials Overview
5.48 MicroPort Scientific Corp Company Overview
5.48.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
5.49 Minvasys SAS Company Overview
5.49.1 Minvasys SAS Pipeline Products & Ongoing Clinical Trials Overview
5.50 MIV Therapeutics Inc Company Overview
5.50.1 MIV Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.51 NanoCoeur, Inc. Company Overview
5.51.1 NanoCoeur, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.52 Nanova, Inc Company Overview
5.52.1 Nanova, Inc Pipeline Products & Ongoing Clinical Trials Overview
5.53 National University of Ireland Galway Company Overview
5.53.1 National University of Ireland Galway Pipeline Products & Ongoing Clinical Trials Overview
5.54 Nesstent Ltd. Company Overview
5.54.1 Nesstent Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.55 Nexeon MedSystems Inc Company Overview
5.55.1 Nexeon MedSystems Inc Pipeline Products & Ongoing Clinical Trials Overview
5.56 North Carolina State University Company Overview
5.56.1 North Carolina State University Pipeline Products & Ongoing Clinical Trials Overview
5.57 Northwestern University Company Overview
5.57.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
5.58 NuVascular Technologies Inc Company Overview
5.58.1 NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.59 OrbusNeich Company Overview
5.59.1 OrbusNeich Pipeline Products & Ongoing Clinical Trials Overview
5.60 Palmaz Scientific Inc (Inactive) Company Overview
5.60.1 Palmaz Scientific Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.61 Pediastent LLC Company Overview
5.61.1 Pediastent LLC Pipeline Products & Ongoing Clinical Trials Overview
5.62 QualiMed Innovative Medizinprodukte GmbH Company Overview
5.62.1 QualiMed Innovative Medizinprodukte GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.63 Qvanteq AG Company Overview
5.63.1 Qvanteq AG Pipeline Products & Ongoing Clinical Trials Overview
5.64 Relisys Medical Devices Ltd Company Overview
5.64.1 Relisys Medical Devices Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.65 REVA Medical Inc Company Overview
5.65.1 REVA Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.66 Rontis AG Company Overview
5.66.1 Rontis AG Pipeline Products & Ongoing Clinical Trials Overview
5.67 S3V Vascular Technologies Company Overview
5.67.1 S3V Vascular Technologies Pipeline Products & Ongoing Clinical Trials Overview
5.68 Sahajanand Medical Technologies Pvt Ltd Company Overview
5.68.1 Sahajanand Medical Technologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.69 Shanghai Bio-heart Biological Technology Co Ltd Company Overview
5.69.1 Shanghai Bio-heart Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.70 Sino Medical Sciences Technology Inc Company Overview
5.70.1 Sino Medical Sciences Technology Inc Pipeline Products & Ongoing Clinical Trials Overview
5.71 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview
5.71.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview
5.72 Stentys SA Company Overview
5.72.1 Stentys SA Pipeline Products & Ongoing Clinical Trials Overview
5.73 Svelte Medical Systems Inc Company Overview
5.73.1 Svelte Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
5.74 Tepha Inc Company Overview
5.74.1 Tepha Inc Pipeline Products & Ongoing Clinical Trials Overview
5.75 Terumo Corp Company Overview
5.75.1 Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview
5.76 Terumo Interventional Systems Company Overview
5.76.1 Terumo Interventional Systems Pipeline Products & Ongoing Clinical Trials Overview
5.77 TissueGen Inc Company Overview
5.77.1 TissueGen Inc Pipeline Products & Ongoing Clinical Trials Overview
5.78 Tremedics Medical Devices LLC Company Overview
5.78.1 Tremedics Medical Devices LLC Pipeline Products & Ongoing Clinical Trials Overview
5.79 TrendyMED Inc. Company Overview
5.79.1 TrendyMED Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.80 University of Alabama at Birmingham Company Overview
5.80.1 University of Alabama at Birmingham Pipeline Products & Ongoing Clinical Trials Overview
5.81 University of Colorado Company Overview
5.81.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview
5.82 University of Florida Company Overview
5.82.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview
5.83 University of Michigan Company Overview
5.83.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview
5.84 University of Strathclyde Company Overview
5.84.1 University of Strathclyde Pipeline Products & Ongoing Clinical Trials Overview
5.85 University of Utah Company Overview
5.85.1 University of Utah Pipeline Products & Ongoing Clinical Trials Overview
5.86 VasoTech Inc. Company Overview
5.86.1 VasoTech Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.87 Viller Scientific LLC Company Overview
5.87.1 Viller Scientific LLC Pipeline Products & Ongoing Clinical Trials Overview
5.88 Vornia Biomaterials Ltd Company Overview
5.88.1 Vornia Biomaterials Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.89 Xenogenics Corporation Company Overview
5.89.1 Xenogenics Corporation Pipeline Products & Ongoing Clinical Trials Overview
6 Coronary Stents- Recent Developments
7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact the Publisher
7.4 Disclaimer
List of Tables
  • Coronary Stents - Pipeline Products by Stage of Development
  • Coronary Stents - Pipeline Products by Segment
  • Coronary Stents - Pipeline Products by Territory
  • Coronary Stents - Pipeline Products by Regulatory Path
  • Coronary Stents - Pipeline Products by Estimated Approval Date
  • Coronary Stents - Ongoing Clinical Trials
  • Coronary Stents Companies - Pipeline Products by Stage of Development
  • Coronary Stents - Pipeline Products by Stage of Development
  • Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Second Generation Bioresorbable Vascular Scaffold - Product Status
  • Second Generation Bioresorbable Vascular Scaffold - Product Description
  • Glossary

List of Figures
  • Coronary Stents - Pipeline Products by Stage of Development
  • Coronary Stents - Pipeline Products by Segment
  • Coronary Stents - Pipeline Products by Territory
  • Coronary Stents - Pipeline Products by Regulatory Path
  • Coronary Stents - Pipeline Products by Estimated Approval Date
  • Coronary Stents - Ongoing Clinical Trials

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Abbott Vascular Inc
  • Adcomp Technologies Inc.
  • Advanced Bifurcation Systems Inc
  • Aeon Bioscience
  • AlviMedica Medical Technologies Inc
  • Amaranth Medical Inc
  • Atrium Medical Corp
  • Axordia Ltd (Inactive)
  • B. Braun Melsungen AG
  • Bactiguard Holding AB
  • Bionext Biotech Products Ltd.
  • Biosensors International Group Ltd
  • Biosten, LLC
  • Biotronik AG
  • Biotronik SE & Co KG
  • Biotyx Medical
  • Boston Scientific Corp
  • Cardionovum GmbH
  • Cardiorev Pte Ltd (Inactive)
  • Columbia University
  • Concept Medical Inc
  • Contego Medical LLC
  • Cordis Corp
  • Cytograft Tissue Engineering Inc (Inactive)
  • DISA Vascular (Pty) Ltd
  • Elixir Medical Corp
  • Envision Scientific Pvt Ltd
  • HangZhou HuaAn Biotechnology Co., Ltd.
  • I.B.S. S.p.A.
  • Icon Interventional Systems, Inc.
  • ID Nest Medical SAS
  • InspireMD Inc
  • Japan Stent Technology Co., Ltd.
  • JW Medical Systems Ltd
  • Kaneka Corp
  • Kyoto Medical Planning Co Ltd
  • Liaoning Biomedical Materials R&D Center Co Ltd
  • Lifetech Scientific (Shenzhen) Co Ltd
  • MangoGen Pharma Inc
  • Manli Cardiology Ltd
  • Medinol Ltd
  • Medlogics Device Corp (Inactive)
  • Medtronic Plc
  • Meril Life Sciences Pvt Ltd
  • Miami Cardiovascular Innovations
  • Micell Technologies Inc
  • Michigan Technological University
  • MicroPort Scientific Corp
  • Minvasys SAS
  • MIV Therapeutics Inc
  • NanoCoeur, Inc.
  • Nanova, Inc
  • National University of Ireland Galway
  • Nesstent Ltd.
  • Nexeon MedSystems Inc
  • North Carolina State University
  • Northwestern University
  • NuVascular Technologies Inc
  • OrbusNeich
  • Palmaz Scientific Inc (Inactive)
  • Pediastent LLC
  • QualiMed Innovative Medizinprodukte GmbH
  • Qvanteq AG
  • Relisys Medical Devices Ltd
  • REVA Medical Inc
  • Rontis AG
  • S3V Vascular Technologies
  • Sahajanand Medical Technologies Pvt Ltd
  • Shanghai Bio-heart Biological Technology Co Ltd
  • Sino Medical Sciences Technology Inc
  • Sree Chitra Tirunal Institute for Medical Sciences & Technology
  • Stentys SA
  • Svelte Medical Systems Inc
  • Tepha Inc
  • Terumo Corp
  • Terumo Interventional Systems
  • TissueGen Inc
  • Tremedics Medical Devices LLC
  • TrendyMED Inc.
  • University of Alabama at Birmingham
  • University of Colorado
  • University of Florida
  • University of Michigan
  • University of Strathclyde
  • University of Utah
  • VasoTech Inc.
  • Viller Scientific LLC
  • Vornia Biomaterials Ltd
  • Xenogenics Corporation